Leizhen Wei

1.8k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

Leizhen Wei is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Leizhen Wei has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Genetics. Recurrent topics in Leizhen Wei's work include DNA Repair Mechanisms (17 papers), CRISPR and Genetic Engineering (5 papers) and PARP inhibition in cancer therapy (5 papers). Leizhen Wei is often cited by papers focused on DNA Repair Mechanisms (17 papers), CRISPR and Genetic Engineering (5 papers) and PARP inhibition in cancer therapy (5 papers). Leizhen Wei collaborates with scholars based in United States, China and Japan. Leizhen Wei's co-authors include Li Lan, C. Elizabeth Shaaban, Satoshi Nakajima, Akira Yasui, Guang Peng, Xiangwei Wu, Lin Yang, Prabodh Kapoor, Qianxing Mo and Gordon B. Mills and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Leizhen Wei

20 papers receiving 1.4k citations

Hit Papers

ARID1A Deficiency Impairs the DNA Damage Checkpoint and S... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leizhen Wei United States 17 1.2k 466 205 186 124 20 1.4k
Amanda W. Kijas Australia 16 963 0.8× 346 0.7× 231 1.1× 122 0.7× 99 0.8× 22 1.1k
Sylvie Thuault France 15 1.0k 0.8× 421 0.9× 388 1.9× 101 0.5× 94 0.8× 18 1.3k
Etsuko Shibata United States 19 1.2k 1.0× 367 0.8× 281 1.4× 66 0.4× 177 1.4× 24 1.3k
Leandros-Vassilios Vassiliou United Kingdom 3 1.4k 1.1× 734 1.6× 297 1.4× 86 0.5× 180 1.5× 4 1.6k
Shirley M.-H. Sy Hong Kong 20 1.5k 1.3× 621 1.3× 298 1.5× 106 0.6× 520 4.2× 26 1.8k
Claire Attwooll United States 9 961 0.8× 375 0.8× 259 1.3× 65 0.3× 170 1.4× 12 1.3k
Scott Davey Canada 18 1.4k 1.2× 523 1.1× 321 1.6× 100 0.5× 107 0.9× 32 1.6k
Colin E.J. Pritchard Netherlands 18 1.0k 0.8× 350 0.8× 135 0.7× 46 0.2× 152 1.2× 34 1.3k
Elizabeth L. Christie Australia 13 498 0.4× 403 0.9× 267 1.3× 77 0.4× 66 0.5× 24 883
Richard H. van Jaarsveld Netherlands 9 566 0.5× 511 1.1× 231 1.1× 95 0.5× 185 1.5× 12 1.0k

Countries citing papers authored by Leizhen Wei

Since Specialization
Citations

This map shows the geographic impact of Leizhen Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leizhen Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leizhen Wei more than expected).

Fields of papers citing papers by Leizhen Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leizhen Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leizhen Wei. The network helps show where Leizhen Wei may publish in the future.

Co-authorship network of co-authors of Leizhen Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Leizhen Wei. A scholar is included among the top collaborators of Leizhen Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leizhen Wei. Leizhen Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hao, Haibo Yang, Xiaolan Zhu, et al.. (2020). m5C modification of mRNA serves a DNA damage code to promote homologous recombination. Nature Communications. 11(1). 2834–2834. 135 indexed citations
2.
Zang, Yachen, Laura E. Pascal, Yibin Zhou, et al.. (2017). ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells. Cancer Letters. 415. 198–207. 14 indexed citations
3.
Gao, Ying, Changling Li, Leizhen Wei, et al.. (2017). SSRP1 Cooperates with PARP and XRCC1 to Facilitate Single-Strand DNA Break Repair by Chromatin Priming. Cancer Research. 77(10). 2674–2685. 35 indexed citations
4.
Wei, Leizhen, et al.. (2016). Transcription-coupled homologous recombination after oxidative damage. DNA repair. 44. 76–80. 18 indexed citations
5.
Wei, Leizhen, et al.. (2016). The Lys63-deubiquitylating Enzyme BRCC36 Limits DNA Break Processing and Repair. Journal of Biological Chemistry. 291(31). 16197–16207. 37 indexed citations
6.
Shen, Jianfeng, Yang Peng, Leizhen Wei, et al.. (2015). ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors. Cancer Discovery. 5(7). 752–767. 358 indexed citations breakdown →
8.
Xing, Mengtan, Mingrui Yang, Wei Huo, et al.. (2015). Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway. Nature Communications. 6(1). 6233–6233. 133 indexed citations
9.
Lan, Li, Guang Peng, Ying‐Nai Wang, et al.. (2015). Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response. Cell Research. 25(2). 225–236. 35 indexed citations
10.
Wei, Leizhen, Satoshi Nakajima, Stefanie Böhm, et al.. (2015). DNA damage during the G0/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination. Proceedings of the National Academy of Sciences. 112(27). E3495–504. 125 indexed citations
11.
Fang, Qingming, Xiaohong Wang, Leizhen Wei, et al.. (2014). HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase β. Nature Communications. 5(1). 5513–5513. 98 indexed citations
12.
Nakajima, Satoshi, Li Lan, Leizhen Wei, et al.. (2014). Ubiquitin-Specific Protease 5 Is Required for the Efficient Repair of DNA Double-Strand Breaks. PLoS ONE. 9(1). e84899–e84899. 53 indexed citations
14.
Kanno, Shin‐ichiro, Masahiro Nakayama, Leizhen Wei, et al.. (2013). The BRCA1/BARD1-Interacting Protein OLA1 Functions in Centrosome Regulation. Molecular Cell. 53(1). 101–114. 56 indexed citations
15.
Benitez, Anaid, Fenghua Yuan, Satoshi Nakajima, et al.. (2013). Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein. Nucleic Acids Research. 42(3). 1671–1683. 14 indexed citations
16.
Wei, Leizhen, Satoshi Nakajima, Shin-ichiro Kanno, et al.. (2013). Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose). Journal of Cell Science. 126(19). 4414–4423. 63 indexed citations
17.
Lan, Li, Satoshi Nakajima, Leizhen Wei, et al.. (2013). Novel method for site-specific induction of oxidative DNA damage reveals differences in recruitment of repair proteins to heterochromatin and euchromatin. Nucleic Acids Research. 42(4). 2330–2345. 86 indexed citations
18.
Gao, Min, Leizhen Wei, Qian Xu, et al.. (2012). A Novel Role of Human Holliday Junction Resolvase GEN1 in the Maintenance of Centrosome Integrity. PLoS ONE. 7(11). e49687–e49687. 17 indexed citations
19.
Wei, Leizhen, Li Lan, Akira Yasui, et al.. (2011). BRCA1 contributes to transcription‐coupled repair of DNA damage through polyubiquitination and degradation of Cockayne syndrome B protein. Cancer Science. 102(10). 1840–1847. 40 indexed citations
20.
Wei, Leizhen, Li Lan, Zehui Hong, et al.. (2008). Rapid Recruitment of BRCA1 to DNA Double-Strand Breaks Is Dependent on Its Association with Ku80. Molecular and Cellular Biology. 28(24). 7380–7393. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026